Trials to watch: Four biologics concluding pivotal COPD trials
The chronic obstructive pulmonary disorder (COPD) market has laid relatively dormant for the past few years until recently. Several biologics…
The chronic obstructive pulmonary disorder (COPD) market has laid relatively dormant for the past few years until recently. Several biologics…
Passage Bio has plans to talk with the US Food and Drug Administration (FDA) to initiate trials of its investigative…
Gilead received a standing ovation after announcing its full, perfect efficacy data from the Phase III PURPOSE 1 trial of…
One of the largest-head-to-head trials shows that a two-drug regimen of Dovato is as effective as a three-drug regimen of…
As sub-Saharan African countries introduce more anti-homosexuality bills, there are concerns they could create a barrier to the LGBTQI+ community…
Researchers will present data from a ‘first-of-its-kind HIV cure’ stem cell transplant at the upcoming AIDS 2024 Conference. Experts will…
AVEO Oncology has announced a Phase III flop of its advanced metastatic renal cell carcinoma (RCC) combination therapy but has…
As technology evolves and it becomes easier to collect data, the question is now if data collection has tipped too…
Gilead Sciences will announce data from several ongoing trials in human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS)…
Kazia Therapeutics’s stocks have skyrocketed by more than 250% after succeeding in a Phase II/III trial in glioblastoma. The company…